Oncology & Cancer

Protein expression predicts rectal cancer outcomes

(HealthDay)—Loss of E-cadherin protein expression in the pretherapeutic biopsy of rectal cancer is associated with fewer metastases and improved survival, according to a study published online March 25 in the Journal of ...

Oncology & Cancer

Colorectal Diseases Biobank links genetics and colorectal cancer

What if your family's DNA could become the blueprint for your very own precise and personalized treatment for colorectal cancer? Or, better yet, what if it could be used to help doctors screen you earlier for the disease, ...

Oncology & Cancer

Colorectal cancer statistics, 2017

Despite dramatic reductions in overall colorectal cancer incidence and mortality, striking disparities by age, race, and tumor subsite remain. That's according to the latest edition of Colorectal Cancer Statistics and its ...

Surgery

Review: noncomplete mesorectal excision up with laparoscopy

(HealthDay)—Patients undergoing laparoscopic rectal resection (LRR) have increased risk for noncomplete mesorectal excision versus those undergoing open rectal resection (ORR), according to a review and meta-analysis published ...

Oncology & Cancer

New method reduces adverse effects of rectal cancer treatment

A new study from Karolinska Institutet shows that short-course preoperative radiotherapy combined with delayed surgery reduces the adverse side-effects of rectal cancer surgery without compromising its efficacy. The results ...

Oncology & Cancer

Prostate cancer—what you need to know

In 2016, more than 180,890 men will be diagnosed with prostate cancer, the second leading cause of cancer death in men. Next to skin cancers, prostate cancer is the most common cancer diagnosed in American men.

page 5 from 11